Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Barbeau

Showing results (61-70 of 319) with videos related to

Pageof 32
Sort By:
Neuroscience Letters|November 20, 1985
1-Methyl-4-phenyl-pyridinium-induced inhibition of nicotinamide adenosine dinucleotide cytochrome c reductaseJ Poirier, A Barbeau
Neuroscience Letters|April 10, 1987
Erythrocyte antioxidant activity in human patients with Parkinson's diseaseJ Poirier, A Barbeau
Lancet (London, England)|May 30, 1970
Treatment of Wilson's disease with L-dopa after failure with penicillamineA Barbeau, H Friesen
Neurology|May 1, 1976
Six-year results of treatment with levodopa plus benzerazide in Parkinson's diseaseA Barbeau, M Roy
L'Union Medicale Du Canada|April 1, 1977
[Gilles de la Tourette's disease]M Gonge, A Barbeau
Research Communications in Chemical Pathology and Pharmacology|June 1, 1987
MPTP potentiates iron-induced lipid peroxidation without the involvement of free radicals derived from oxygenJ Poirier, A Barbeau
Biochemical and Biophysical Research Communications|September 30, 1985
A catalyst function for MPTP in superoxide formationJ Poirier, A Barbeau
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1982
New data on the genetics of Parkinson's diseaseA Barbeau, E Pourcher
Lancet (London, England)|April 26, 1975
Letter: Dopamine and Huntington's choreaA Barbeau, K Ando
Archives of Neurology|January 1, 1974
Zinc, taurine, and epilepsyA Barbeau, J Donaldson
Pageof 32

Showing results (61-70 of 319) with videos related to

Sort By:
Pageof 32
Neuroscience Letters|November 20, 1985
1-Methyl-4-phenyl-pyridinium-induced inhibition of nicotinamide adenosine dinucleotide cytochrome c reductaseJ Poirier, A Barbeau
Neuroscience Letters|April 10, 1987
Erythrocyte antioxidant activity in human patients with Parkinson's diseaseJ Poirier, A Barbeau
Lancet (London, England)|May 30, 1970
Treatment of Wilson's disease with L-dopa after failure with penicillamineA Barbeau, H Friesen
Neurology|May 1, 1976
Six-year results of treatment with levodopa plus benzerazide in Parkinson's diseaseA Barbeau, M Roy
L'Union Medicale Du Canada|April 1, 1977
[Gilles de la Tourette's disease]M Gonge, A Barbeau
Research Communications in Chemical Pathology and Pharmacology|June 1, 1987
MPTP potentiates iron-induced lipid peroxidation without the involvement of free radicals derived from oxygenJ Poirier, A Barbeau
Biochemical and Biophysical Research Communications|September 30, 1985
A catalyst function for MPTP in superoxide formationJ Poirier, A Barbeau
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1982
New data on the genetics of Parkinson's diseaseA Barbeau, E Pourcher
Lancet (London, England)|April 26, 1975
Letter: Dopamine and Huntington's choreaA Barbeau, K Ando
Archives of Neurology|January 1, 1974
Zinc, taurine, and epilepsyA Barbeau, J Donaldson
Pageof 32